|
Pagan-Escribano J, Corral J, Minano A, Padilla J, Roldan V, Hernandez-Vidal MJ, Lozano J, de la Morena-Barrio I, Vicente V, Lozano ML, Herranz MT, de la Morena-Barrio ME. Factor XI in Carriers of Antiphospholipid Antibodies: Elevated Levels Associated with Symptomatic Thrombotic Cases, While Low Levels Linked to Asymptomatic Cases. Int J Mol Sci. 2023 Nov 13;24(22):16270. doi: 10.3390/ijms242216270. PubMed PMID: 38003459; PubMed Central PMCID: PMC10670960.
AÑO: 2023; IF: 4.9
|
38003459
|
Serna MJ, Rivera-Caravaca JM, Lopez-Galvez R, Soler-Espejo E, Lip GYH, Marin F, Roldan V. Dynamic assessment of CHA2DS2-VASc and HAS-BLED scores for predicting ischemic stroke and major bleeding in atrial fibrillation patients. Rev Esp Cardiol (Engl Ed). 2024 Oct;77(10):835-842. doi: 10.1016/j.rec.2024.02.011. Epub 2024 Mar 7. English, Spanish. PubMed PMID: 38460882.
AÑO: 2024; IF: 4.9
|
|
Piqueras-Sanchez C, Esteve-Pastor MA, Moreno-Fernandez J, Soler-Espejo E, Rivera-Caravaca JM, Roldan V, Marin F. Advances in the medical treatment and diagnosis of intracranial hemorrhage associated with oral anticoagulation. Expert Rev Neurother. 2024 Sep;24(9):913-928. doi: 10.1080/14737175.2024.2379413. Epub 2024 Jul 22. PubMed PMID: 39039686.
AÑO: 2024; IF: 3.4
|
|
Soler-Espejo E, Rivera-Caravaca JM, Bru-Canovas JD, Esteve-Pastor MA, Lip GYH, Marin F, Roldan V. Patients with atrial fibrillation and common exclusion criteria from clinical trials are at high risk of clinical events: the Murcia AF Project II (MAFP-II) cohort study. Intern Emerg Med. 2024 Oct;19(7):1941-1948. doi: 10.1007/s11739-024-03701-9. Epub 2024 Jul 4. PubMed PMID: 38965203; PubMed Central PMCID: PMC11467067.
AÑO: 2024; IF: 3.8
|
|
Poveda-Garcia A, Ruiz E, Moreno MJ, Espanol I, Sanchez-Salinas A, Garcia-Hernandez AM, Blanquer M, Martinez I, Sanchez-Villalobos M, Garcia Garay MC, Salido E, Heredia A, Navarro-Almenzar B, Monserrat J, Sanchez-Salas JA, Martinez-Mellado AJ, Minguela A, Campillo JA, Lopez-Hernandez R, Galian JA, Moraleda JM, Roldan V, Cabanas V. Real-world outcomes of tandem ASCT in newly diagnosed multiple myeloma patients with standard risk features: a single-center analysis. Bone Marrow Transplant. 2024 Nov;59(11):1625-1627. doi: 10.1038/s41409-024-02404-1. Epub 2024 Aug 26. No abstract available. PubMed PMID: 39187602.
AÑO: 2024; IF: 5.2
|